| 2024-10-01 |
详情>>
股本变动：
变动后总股本63264.08万股
|
| 2024-09-30 |
详情>>
业绩披露：
2024年中报每股收益-0.12欧元,归母净利润-8694.9万欧元,同比去年增长77.44%
|
| 2024-08-30 |
股东大会：
将于2024-09-18召开股东大会
会议内容 ▼▲
- 1.To openingBoard Composition.
2.To appointment of Non-Executive Director, Appointment of Philippe Balducchi as Non-Executive Director for a period of 1 year with effect as of this General Meeting (voting item).
3.To re-appointment of Non-Executive Director: a.Re-appointment of Thomas Enders as Non-Executive Director for a period of 1 year with effect as of the annual general meeting to be held in 2024 (voting item), b.Re-appointment of David Wallerstein as Non-Executive Director for a period of 1 year with effect as of the annual general meeting to be held in 2024 (voting item), c.e-appointment of Niklas Zennstrm as Non-Executive Director for a period of 1 year with effect as of the annual general meeting to be held in 2024 (voting item), d.Re-appointment of Gabrielle Toledano as Non-Executive Director for a period of 1 year with effect as of the annual general meeting to be held in 2024 (voting item), e.Re-appointment of David Neeleman as Non-Executive Director for a period of 1 year with effect as of the annual general meeting to be held in 2024 (voting item), fRe-appointment of Margaret M. Smyth as Non-Executive Director for a period of 1 year with effect as of the annual general meeting to be held in 2024 (voting item).
|
| 2024-06-11 |
财报披露：
美东时间 2024-06-11 盘前发布财报
|
| 2024-05-03 |
股东大会：
将于2024-05-30召开股东大会
会议内容 ▼▲
- 1.Opening
2.Designation of the Board as the competent body to issue and grant rights to subscribe for Shares A in the share capital of the Company up to a maximum of 15% of the issued capital at the date of the General Meeting for a period of 36 months from the General Meeting and to limit or exclude statutory pre-emptive rights related thereto (voting item)
3.Any other business (discussion item)
4.Closing
|
| 2024-03-15 |
详情>>
业绩披露：
2023年年报每股收益-0.71欧元,归母净利润-3.89亿欧元,同比去年增长-53.76%
|
| 2023-09-15 |
详情>>
业绩披露：
2023年中报每股收益-0.89欧元,归母净利润-3.85亿欧元,同比去年增长-211.64%
|
| 2023-06-12 |
股东大会：
将于2023-07-07召开股东大会
会议内容 ▼▲
- 1.Opening.
2.Re-appointment of Non-Executive Directors.
Re-appointment of Thomas Enders as Non-Executive Director for a period of 1 year (voting item).
Re-appointment of David Wallerstein as Non-Executive Director for a period of 1 year (voting item).
Re-appointment of Niklas Zennstrm as Non-Executive Director for a period of 1 year (voting item).
Re-appointment of Gabrielle Toledano as Non-Executive Director for a period of 1 year (voting item).
Re-appointment of Henri Courpron as Non-Executive Director for a period of 1 year (voting item).
Re-appointment of David Neeleman as Non-Executive Director for a period of 1 year (voting item).
Re-appointment of Margaret M. Smyth as Non-Executive Director for a period of 1 year (voting item)
3.Discussion of the 2022 annual report (discussion item).
4.Discussion and adoption of the 2022 financial statements (voting item).
5.Discussion of the Company’s dividend policy and the allocation of the Company’s 2022 losses to the Company’s retained earnings (discussion item).
6.Discharge of the Directors.
Discharge of the Executive Directors (voting item).
Discharge of the Non-Executive Directors (voting item).
7.Designation of the Board as the competent body to issue shares and grant rights to subscribe for shares A in the share capital of the Company up to a maximum of 10% of the issued share capital of the Company at the date of the Annual General Meeting for a period of 36 months from the Annual General Meeting and to limit or exclude statutory pre-emptive rights related thereto (voting item).
8.Reduction of issued share capital of the Company by a cancellation of 770,000 shares C held by the Company in treasury (voting item).
9.Any other business (discussion item).
10.Closing.
|
| 2023-05-03 |
股东大会：
将于2023-05-25召开股东大会
会议内容 ▼▲
- 1.Opening.
2.Reduction of share capital by reducing the nominal value of each Share A, each Share B, and each Share C and amendment of the articles of association of Lilium (voting item).
3.Designation of the Board as the competent body to issue and grant rights to subscribe for Shares A in the share capital of the Company up to a maximum of 30% of the issued capital at the date of the General Meeting for a period of 36 months from the General Meeting and to limit or exclude statutory pre-emptive rights related thereto (voting item).
4.The authorization, for the purpose of Nasdaq Listing Rule 5635(b), to issue Shares A that would result in a beneficial ownership of Shares A in excess of 19.99% of the Company’s ordinary shares outstanding, upon the potential future exercise of certain outstanding warrants by Tencent Holdings Limited and its affiliates, including Aceville Pte. Limited, and upon the potential future exercise of such outstanding warrants by any future registered holder of such warrants (voting item).
5.Any other business (discussion item)
6.Closing.
|
| 2023-03-28 |
详情>>
业绩披露：
2022年年报每股收益-0.8欧元,归母净利润-2.53亿欧元,同比去年增长38.43%
|
| 2022-12-06 |
股东大会：
将于2022-12-21召开股东大会
会议内容 ▼▲
- 1.Confirm, and to the extent necessary ratify, that the board report - as included in the annual financial statements - could be prepared in English.
2.Discussion of the 2021 annual report.
3.Discussion and adoption of the 2021 financial statements.
4.Discussion of the Company’s dividend policy and the allocation of the Company’s 2021 losses to the Company’s retained earnings.
5.Discharge of the Directors.
6.Designation of the Board to issue shares and grant rights to subscribe for shares A in the share capital of the Company up to a maximum of 25% of the issued capital at the date of the Annual General Meeting for a period of 36 months from the Annual General Meeting and to limit or exclude statutory pre-emptive rights related thereto.
7.Reduction of issued share capital by a cancellation of 50,000 shares B held by the Company in treasury.
8.Reduction of issued share capital by a cancellation of 105,000 shares C held by the Company in treasury.
9.Amendment of the compensation policy of Lilium to cover compensation for the non-executive directors who will serve on the newly created sustainability committee of Lilium.
10.Any other business.
|
| 2022-09-28 |
详情>>
业绩披露：
2022年中报每股收益-0.43欧元,归母净利润-1.24亿欧元,同比去年增长-633.41%
|
| 2022-09-26 |
股东大会：
将于2022-10-27召开股东大会
会议内容 ▼▲
- 1.Appointment of Executive Director.
2.Re-appointment of Non-Executive Directors.
3.Designation of the Board to issue shares and grant rights to subscribe for shares A and shares B in the share capital of the Company up to a maximum of 25% of the outstanding capital at the date of the General Meeting for a period of 24 months from the General Meeting and to limit or exclude statutory pre-emptive rights related thereto.
4.Amendment of the articles of association of Lilium and granting of a proxy to each of the directors of the Company and employees of Freshfields Bruckhaus Deringer LLP, Amsterdam office, in having the deed of amendment executed.
5.Reduction of issued share capital by a cancellation of 375,000 shares B held by the Company in treasury.
6.Any other business.
|
| 2022-03-30 |
详情>>
业绩披露：
2021年年报每股收益-1.91欧元,归母净利润-4.11亿欧元,同比去年增长-139843.82%
|
| 2021-09-14 |
详情>>
内部人交易：
Qell Partners LLC共交易2笔
|
| 2021-08-11 |
股东大会：
将于2021-09-10召开股东大会
会议内容 ▼▲
- 1.To adopt and approve the Business Combination Agreement and the transactions contemplated thereby, including the Business Combination;
2.To adopt and approve the Merger, along with the Merger Documents, including the Plan of Merger, and the transactions contemplated thereby;
3.To adopt and approve the Holdco 2021 Equity Incentive Plan (the “Incentive Plan”), which will be substantially in the form attached to the accompanying proxy statement/prospectus as Annex C, including the authorization of the initial share reserve under the Incentive Plan;
4.To adopt and approve the Holdco 2021 Employee Share Purchase Plan (the “ESPP”), a copy of which is attached to this proxy statement/prospectus as Annex D, including the authorization of the initial share reserve under the ESPP;
5.To consider and vote upon a proposal to adjourn the General Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies if there are insufficient votes for, or otherwise in connection with, the approval of the Business Combination Proposal and the Merger Proposal. The Adjournment Proposal will only be presented to Qell shareholders in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Business Combination Proposal or the Merger Proposal.
|
| 2021-03-31 |
详情>>
业绩披露：
2020年年报每股收益0.00欧元,归母净利润-29.37万欧元,同比去年增长99.54%
|